Blough B - Search Results

1

Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.

Severinsen K, Kraft JF, Koldsø H, Vinberg KA, Rothman RB, Partilla JS, Wiborg O, Blough B, Schiøtt B, Sinning S. Severinsen K, et al. Among authors: blough b. ACS Chem Neurosci. 2012 Sep 19;3(9):693-705. doi: 10.1021/cn300040f. Epub 2012 Jun 10. ACS Chem Neurosci. 2012. PMID: 23019496 Free PMC article.

2

Appetite suppressants as agonist substitution therapies for stimulant dependence.

Rothman RB, Blough BE, Baumann MH. Rothman RB, et al. Among authors: blough be. Ann N Y Acad Sci. 2002 Jun;965:109-26. doi: 10.1111/j.1749-6632.2002.tb04155.x. Ann N Y Acad Sci. 2002. PMID: 12105089

3

Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.

Rothman RB, Katsnelson M, Vu N, Partilla JS, Dersch CM, Blough BE, Baumann MH. Rothman RB, et al. Among authors: blough be. Eur J Pharmacol. 2002 Jun 28;447(1):51-7. doi: 10.1016/s0014-2999(02)01830-7. Eur J Pharmacol. 2002. PMID: 12106802

4

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB. Baumann MH, et al. Among authors: blough be. Neuropsychopharmacology. 2005 Mar;30(3):550-60. doi: 10.1038/sj.npp.1300585. Neuropsychopharmacology. 2005. PMID: 15496938

5

Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.

Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB. Baumann MH, et al. Among authors: blough be. Ann N Y Acad Sci. 2004 Oct;1025:189-97. doi: 10.1196/annals.1316.024. Ann N Y Acad Sci. 2004. PMID: 15542717

6

Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.

Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL. Wee S, et al. Among authors: blough be. J Pharmacol Exp Ther. 2005 May;313(2):848-54. doi: 10.1124/jpet.104.080101. Epub 2005 Jan 26. J Pharmacol Exp Ther. 2005. PMID: 15677348

7

Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.

Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, Baumann MH. Rothman RB, et al. Among authors: blough be. J Pharmacol Exp Ther. 2005 Jun;313(3):1361-9. doi: 10.1124/jpet.104.082503. Epub 2005 Mar 10. J Pharmacol Exp Ther. 2005. PMID: 15761112

8

Interaction of amphetamines and related compounds at the vesicular monoamine transporter.

Partilla JS, Dempsey AG, Nagpal AS, Blough BE, Baumann MH, Rothman RB. Partilla JS, et al. Among authors: blough be. J Pharmacol Exp Ther. 2006 Oct;319(1):237-46. doi: 10.1124/jpet.106.103622. Epub 2006 Jul 11. J Pharmacol Exp Ther. 2006. PMID: 16835371

9

Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.

Rothman RB, Blough BE, Baumann MH. Rothman RB, et al. Among authors: blough be. Trends Pharmacol Sci. 2006 Dec;27(12):612-8. doi: 10.1016/j.tips.2006.10.006. Epub 2006 Oct 23. Trends Pharmacol Sci. 2006. PMID: 17056126

10

Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.

Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB. Negus SS, et al. Among authors: blough be. J Pharmacol Exp Ther. 2007 Feb;320(2):627-36. doi: 10.1124/jpet.106.107383. Epub 2006 Oct 27. J Pharmacol Exp Ther. 2007. PMID: 17071819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters